CHF512.40
8.30% yesterday
SIX Swiss Exchange, Nov 15, 05:31 pm CET
ISIN
CH0013841017
Symbol
LONN
Sector
Industry

Lonza Stock price

CHF512.40
-25.00 4.65% 1M
-19.80 3.72% 6M
+158.70 44.87% YTD
+161.10 45.86% 1Y
-219.40 29.98% 3Y
+171.70 50.40% 5Y
+413.94 420.39% 10Y
SIX Swiss Exchange, Closing price Fri, Nov 15 2024
-46.40 8.30%
ISIN
CH0013841017
Symbol
LONN
Sector
Industry

Key metrics

Market capitalization CHF35.28b
Enterprise Value CHF37.12b
P/E (TTM) P/E ratio 62.78
EV/FCF (TTM) EV/FCF 789.72
EV/Sales (TTM) EV/Sales 5.54
P/S ratio (TTM) P/S ratio 5.27
P/B ratio (TTM) P/B ratio 3.77
Dividend yield 0.72%
Last dividend (FY23) CHF4.00
Revenue growth (TTM) Revenue growth 5.97%
Revenue (TTM) Revenue CHF6.70b
EBIT (operating result TTM) EBIT CHF1.43b
Free Cash Flow (TTM) Free Cash Flow CHF47.00m
EPS (TTM) EPS CHF8.16
P/E forward 48.04
P/S forward 5.76
EV/Sales forward 6.03
Show more

Create a Free Account to create an Lonza alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Lonza Stock Analysis

Analyst Opinions

19 Analysts have issued a Lonza forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a Lonza forecast:

Buy
79%
Hold
21%

Financial data from Lonza

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
6,696 6,696
6% 6%
100%
- Direct Costs 4,740 4,740
19% 19%
71%
1,956 1,956
17% 17%
29%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
2,064 2,064
2% 2%
31%
- Depreciation and Amortization 631 631
4% 4%
9%
EBIT (Operating Income) EBIT 1,433 1,433
5% 5%
21%
Net Profit 573 573
49% 49%
9%

In millions CHF.

Don't miss a Thing! We will send you all news about Lonza directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lonza Stock News

AD HOC NEWS
23 days ago
Lonza Group AG / CH0013841017
AD HOC NEWS
about one month ago
Lonza Group AG / CH0013841017
More Lonza News

Company Profile

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Wolfgang Wienand
Employees 18,000
Founded 1897
Website www.lonza.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today